Chemical news · Three minutes a day
Wednesday, September 2, 2026
Lead Story
Judge Allows Smucker’s Trademark Lawsuit Against Trader Joe’s Over Frozen PB&J to ProceedA federal judge ruled J.M. Smucker can proceed with its trademark lawsuit against Trader Joe’s over frozen PB&J sandwiches, rejecting arguments that the competitor's design was sufficiently distinct from Uncrustables.
Louisiana regulators tentatively approved Blue Sky Infrastructure's application to expand its CO2 storage hub by 8 million metric tons annually. The project involves drilling injection wells to serve industrial emitters including CF Industries and Nucor via ExxonMobil agreements.
Reliance Consumer Products is launching the Bombay Creamery ice cream brand across India with prices starting at 10 rupees, entering a market dominated by competitors like Amul and Vadilal.
SB Energy filed for an IPO backed by SoftBank and OpenAI to fund power infrastructure for AI data centers, including solar, battery storage, and natural gas projects. Analysts project $511 billion in tech power spending by 2030.
Keurig Dr Pepper will sell its Chobani equity stake and a Pennsylvania facility for $925 million to reshape its portfolio post-JDE Peet's acquisition, while Chobani plans $1.2B investment in milk production.
Shell is divesting underperforming US chemical assets valued at up to $8 billion, attracting bids from ExxonMobil and LyondellBasell. The production sites supply plastics, detergents, and pharmaceuticals as the company refocuses on upstream oil and gas operations.
Norwegian oil firm DNO agreed to acquire UK-based Capricorn Energy for $396 million, outbidding rival Genel Energy as rising oil prices fuel M&A activity in the Middle East region.
National Industrialization Co (Tasnee) completed the sale of its subsidiary Al Rowad to Tahweel for SR700 million on August 31. The deal reinforces Tasnee's strategic focus on petrochemicals and improves its financial leverage.
The White House announced a deal granting a private firm access to Venezuelan oil reserves with a U.S. equity stake, raising concerns among major oil producers like ExxonMobil over legal certainty. Chevron continues separate negotiations for energy projects.
Samsung Biologics launched a $2.1 billion rights offering to acquire PolyPeptide Group and expand Bio Campus II capacity. The investment targets peptide-based therapeutics and antibodies, aiming to reach 1.38 million liters of global production by 2032.
ChemBrief